| A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia (NCT04102501) | Biojiva LLC | 2019-10-30 |
| (+) Epicatechin to Treat Friedreich's Ataxia (NCT02660112) | Ralitza Gavrilova | 2016-09-01 |
| A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study) (NCT02840669) | Adverum Biotechnologies, Inc. | 2016-07-01 |
| Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia (NCT02797080) | Amgen | 2016-06-28 |
| Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study (NCT02593773) | Amgen | 2015-12-25 |
| Biomarkers in Friedreich's Ataxia (NCT02497534) | University of Florida | 2015-09-01 |
| A First in Human Study of RT001 in Patients With Friedreich's Ataxia (NCT02445794) | Biojiva LLC | 2015-08-01 |
| Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia (NCT02415127) | Amgen | 2015-06-01 |
| Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA) (NCT02316314) | Weill Medical College of Cornell University | 2015-01-15 |
| EPI-743 in Friedreich's Ataxia Point Mutations (NCT01962363) | University of South Florida | 2013-10-01 |
| Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia (NCT01898884) | Shire | 2013-08-13 |
| An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia (NCT01921868) | University of South Florida | 2013-08-01 |
| Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia (NCT01728064) | PTC Therapeutics | 2012-12-31 |
| Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND) (NCT02179333) | University of South Florida | 2012-10-01 |
| Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI) (NCT01303406) | Santhera Pharmaceuticals | 2011-04-01 |
| Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) (NCT02069509) | European Friedreich's Ataxia Consortium for Translational Studies | 2010-05-01 |
| Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia (NCT01035671) | Penwest Pharmaceuticals Co. | 2009-12-01 |
| Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia (NCT01016366) | H. Lundbeck A/S | 2009-10-01 |
| A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia (NCT00897221) | ApoPharma | 2009-06-01 |
| Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia (NCT00803868) | University of South Florida | 2009-05-01 |
| Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept (NCT00811681) | Assistance Publique - Hôpitaux de Paris | 2008-12-01 |
| Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients (NCT00697073) | Santhera Pharmaceuticals | 2008-07-01 |
| A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia (NCT00530127) | ApoPharma | 2008-04-01 |
| Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia (NCT00631202) | Federico II University | 2008-02-01 |
| Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (NCT00537680) | Santhera Pharmaceuticals | 2007-12-01 |
| A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients (NCT00905268) | Santhera Pharmaceuticals | 2006-04-01 |